nodes	percent_of_prediction	percent_of_DWPC	metapath
Milrinone—Infusion site reaction—Paclitaxel—ovarian cancer	0.132	0.132	CcSEcCtD
Milrinone—Infusion site reaction—Docetaxel—ovarian cancer	0.112	0.112	CcSEcCtD
Milrinone—Thrombocytopenia—Altretamine—ovarian cancer	0.0392	0.0392	CcSEcCtD
Milrinone—Liver function test abnormal—Melphalan—ovarian cancer	0.0233	0.0233	CcSEcCtD
Milrinone—Ventricular extrasystoles—Paclitaxel—ovarian cancer	0.0226	0.0226	CcSEcCtD
Milrinone—Bronchospasm—Melphalan—ovarian cancer	0.0214	0.0214	CcSEcCtD
Milrinone—Ventricular tachycardia—Paclitaxel—ovarian cancer	0.0204	0.0204	CcSEcCtD
Milrinone—Bronchospasm—Vinorelbine—ovarian cancer	0.0187	0.0187	CcSEcCtD
Milrinone—Angina pectoris—Vinorelbine—ovarian cancer	0.0186	0.0186	CcSEcCtD
Milrinone—Tremor—Chlorambucil—ovarian cancer	0.0163	0.0163	CcSEcCtD
Milrinone—Ventricular arrhythmia—Epirubicin—ovarian cancer	0.0158	0.0158	CcSEcCtD
Milrinone—Arrhythmia—Melphalan—ovarian cancer	0.0156	0.0156	CcSEcCtD
Milrinone—Ventricular arrhythmia—Doxorubicin—ovarian cancer	0.0146	0.0146	CcSEcCtD
Milrinone—Thrombocytopenia—Chlorambucil—ovarian cancer	0.0139	0.0139	CcSEcCtD
Milrinone—Liver function test abnormal—Paclitaxel—ovarian cancer	0.0137	0.0137	CcSEcCtD
Milrinone—Arrhythmia—Vinorelbine—ovarian cancer	0.0136	0.0136	CcSEcCtD
Milrinone—Hypokalaemia—Paclitaxel—ovarian cancer	0.0135	0.0135	CcSEcCtD
Milrinone—Chest pain—Topotecan—ovarian cancer	0.0132	0.0132	CcSEcCtD
Milrinone—Chest pain—Melphalan—ovarian cancer	0.0129	0.0129	CcSEcCtD
Milrinone—Ventricular extrasystoles—Epirubicin—ovarian cancer	0.0129	0.0129	CcSEcCtD
Milrinone—Anaphylactic shock—Topotecan—ovarian cancer	0.0127	0.0127	CcSEcCtD
Milrinone—Anaphylactic shock—Melphalan—ovarian cancer	0.0124	0.0124	CcSEcCtD
Milrinone—Thrombocytopenia—Topotecan—ovarian cancer	0.0124	0.0124	CcSEcCtD
Milrinone—Thrombocytopenia—Melphalan—ovarian cancer	0.0121	0.0121	CcSEcCtD
Milrinone—Ventricular extrasystoles—Doxorubicin—ovarian cancer	0.012	0.012	CcSEcCtD
Milrinone—Ventricular tachycardia—Epirubicin—ovarian cancer	0.0117	0.0117	CcSEcCtD
Milrinone—Liver function test abnormal—Docetaxel—ovarian cancer	0.0116	0.0116	CcSEcCtD
Milrinone—Hypotension—Melphalan—ovarian cancer	0.0116	0.0116	CcSEcCtD
Milrinone—Chest pain—Vinorelbine—ovarian cancer	0.0113	0.0113	CcSEcCtD
Milrinone—Anaphylactic shock—Vinorelbine—ovarian cancer	0.0108	0.0108	CcSEcCtD
Milrinone—Ventricular tachycardia—Doxorubicin—ovarian cancer	0.0108	0.0108	CcSEcCtD
Milrinone—Bronchospasm—Docetaxel—ovarian cancer	0.0107	0.0107	CcSEcCtD
Milrinone—Thrombocytopenia—Vinorelbine—ovarian cancer	0.0106	0.0106	CcSEcCtD
Milrinone—Angina pectoris—Docetaxel—ovarian cancer	0.0106	0.0106	CcSEcCtD
Milrinone—Hypotension—Vinorelbine—ovarian cancer	0.0101	0.0101	CcSEcCtD
Milrinone—Arrhythmia—Paclitaxel—ovarian cancer	0.00916	0.00916	CcSEcCtD
Milrinone—Tremor—Paclitaxel—ovarian cancer	0.00836	0.00836	CcSEcCtD
Milrinone—Rash—Topotecan—ovarian cancer	0.00798	0.00798	CcSEcCtD
Milrinone—Dermatitis—Topotecan—ovarian cancer	0.00798	0.00798	CcSEcCtD
Milrinone—Headache—Topotecan—ovarian cancer	0.00793	0.00793	CcSEcCtD
Milrinone—Liver function test abnormal—Epirubicin—ovarian cancer	0.00782	0.00782	CcSEcCtD
Milrinone—Rash—Melphalan—ovarian cancer	0.00782	0.00782	CcSEcCtD
Milrinone—Dermatitis—Melphalan—ovarian cancer	0.00781	0.00781	CcSEcCtD
Milrinone—Arrhythmia—Docetaxel—ovarian cancer	0.00776	0.00776	CcSEcCtD
Milrinone—Hypokalaemia—Epirubicin—ovarian cancer	0.00771	0.00771	CcSEcCtD
Milrinone—Chest pain—Paclitaxel—ovarian cancer	0.0076	0.0076	CcSEcCtD
Milrinone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00728	0.00728	CcSEcCtD
Milrinone—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00724	0.00724	CcSEcCtD
Milrinone—Hypokalaemia—Doxorubicin—ovarian cancer	0.00714	0.00714	CcSEcCtD
Milrinone—Angina pectoris—Epirubicin—ovarian cancer	0.00713	0.00713	CcSEcCtD
Milrinone—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00713	0.00713	CcSEcCtD
Milrinone—Rash—Vinorelbine—ovarian cancer	0.00683	0.00683	CcSEcCtD
Milrinone—Dermatitis—Vinorelbine—ovarian cancer	0.00682	0.00682	CcSEcCtD
Milrinone—Hypotension—Paclitaxel—ovarian cancer	0.00681	0.00681	CcSEcCtD
Milrinone—Headache—Vinorelbine—ovarian cancer	0.00678	0.00678	CcSEcCtD
Milrinone—Angina pectoris—Doxorubicin—ovarian cancer	0.0066	0.0066	CcSEcCtD
Milrinone—Chest pain—Docetaxel—ovarian cancer	0.00644	0.00644	CcSEcCtD
Milrinone—Anaphylactic shock—Docetaxel—ovarian cancer	0.00617	0.00617	CcSEcCtD
Milrinone—Thrombocytopenia—Docetaxel—ovarian cancer	0.00605	0.00605	CcSEcCtD
Milrinone—Hypotension—Docetaxel—ovarian cancer	0.00577	0.00577	CcSEcCtD
Milrinone—Arrhythmia—Epirubicin—ovarian cancer	0.00524	0.00524	CcSEcCtD
Milrinone—Arrhythmia—Doxorubicin—ovarian cancer	0.00485	0.00485	CcSEcCtD
Milrinone—Rash—Paclitaxel—ovarian cancer	0.00459	0.00459	CcSEcCtD
Milrinone—Dermatitis—Paclitaxel—ovarian cancer	0.00459	0.00459	CcSEcCtD
Milrinone—Headache—Paclitaxel—ovarian cancer	0.00456	0.00456	CcSEcCtD
Milrinone—Chest pain—Epirubicin—ovarian cancer	0.00434	0.00434	CcSEcCtD
Milrinone—Anaphylactic shock—Epirubicin—ovarian cancer	0.00416	0.00416	CcSEcCtD
Milrinone—Thrombocytopenia—Epirubicin—ovarian cancer	0.00408	0.00408	CcSEcCtD
Milrinone—Chest pain—Doxorubicin—ovarian cancer	0.00402	0.00402	CcSEcCtD
Milrinone—Rash—Docetaxel—ovarian cancer	0.00389	0.00389	CcSEcCtD
Milrinone—Hypotension—Epirubicin—ovarian cancer	0.00389	0.00389	CcSEcCtD
Milrinone—Dermatitis—Docetaxel—ovarian cancer	0.00389	0.00389	CcSEcCtD
Milrinone—Headache—Docetaxel—ovarian cancer	0.00387	0.00387	CcSEcCtD
Milrinone—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00385	0.00385	CcSEcCtD
Milrinone—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00377	0.00377	CcSEcCtD
Milrinone—Hypotension—Doxorubicin—ovarian cancer	0.0036	0.0036	CcSEcCtD
Milrinone—Rash—Epirubicin—ovarian cancer	0.00263	0.00263	CcSEcCtD
Milrinone—Dermatitis—Epirubicin—ovarian cancer	0.00262	0.00262	CcSEcCtD
Milrinone—Headache—Epirubicin—ovarian cancer	0.00261	0.00261	CcSEcCtD
Milrinone—Rash—Doxorubicin—ovarian cancer	0.00243	0.00243	CcSEcCtD
Milrinone—Dermatitis—Doxorubicin—ovarian cancer	0.00243	0.00243	CcSEcCtD
Milrinone—Headache—Doxorubicin—ovarian cancer	0.00241	0.00241	CcSEcCtD
